Medical Cannabis News


Pregnant women’s medical cannabis and CBD intake on the rise: American Medical Association

According to a new statistical study featured in the American Medical Association’s online journal, there has been an increase in the number of pregnant women consuming cannabis as compared to previous years. The study shows that the number of women choosing to use cannabis during their gestation period between 2016 and 2017 increased by 7 %. This study’s results vary significantly with the results of a previous study conducted between 2002 and 2003. According to the previous study, which used the same parameters, only 3% of women during this period opted to use cannabis.


Rising rates of marijuana use among pregnant women spark concern

Increasing numbers of pregnant women are using marijuana in the U.S. and that may result in issues for their babies, two new studies suggest.

Researchers found that the proportion of U.S. women using pot during pregnancy more than doubled between 2002 and 2017, according to a report published in JAMA.

Legalization may at least partly explain why more women are using marijuana since many assume that means the drug is safe, said the U.S. study's lead author, Dr. Nora Volkow, director of the National Institute on Drug Abuse. That attitude, coupled with the lack of studies on pot can lead to "magical thinking," Volkow said. "It's very appealing to think that a drug that makes us feel great could come with no ill effects."


Why cannabinoid company Botanix rocketed 25% higher today

The Botanix Pharmaceuticals Ltd (ASX: BOT) share price has been a standout performer on the Australian share market on Thursday. In morning trade the clinical stage cannabinoid company’s shares rocketed 25% higher to an all-time high of 17.5 cents.

Why did the Botanix share price rocket higher today?

Hot on the heels of a positive update on its BTX 1308 psoriasis Phase 1b mechanism of action study on Wednesday, this morning the company released an update on its BTX 1801 antimicrobial product.

According to the release, the company has received positive new data from studies recently conducted at The University of Queensland’s Institute for Molecular Bioscience’s Centre for Superbug Solutions.


Medical cannabis use uncovers new possibilities for patients

Medical cannabis legalization has been sweeping throughout countries worldwide as many look for alternatives to traditionally prescribed treatments and medications. Before the modern era, cannabis was a popular herbal medicinal treatment in Chinese, Indian, Egyptian, and Islamic cultures. However, under international regulations, cannabis was deemed illegal nearly a century ago because of the psychoactive properties stemming from the marijuana derivative of the plant. However, despite regulatory laws, many countries have since decided to move forward and legalize medical cannabis due to its therapeutic benefits. Countries such as Australia, Canada, Chile, Czech Republic, Germany, Italy, Mexico, the U.K, and parts of the U.S. have all adopted medicinal cannabis legislation.


Low THC levels not linked to car crashes: UBC study

University of B.C. researchers say Canada’s impaired driving laws may be too strict when it comes to low levels of THC.

The UBC study, published in the journal Addiction, found that THC levels less than five nanograms/ml of blood do not lead to an increased risk of causing car crashes in most drivers.

Canadian drug-impaired driving laws penalize drivers found to have blood THC levels of between two to five nanograms/ml with fines.

Dr. Jeffrey Brubacher, associate professor in the department of emergency medicine at UBC and lead researcher on the five-year study said in an interview Thursday that he would recommend Canada’s laws be changed to not penalize someone with under five nanograms/ml in their blood.


This national grocery chain will carry CBD in 17 states

In case you haven't been paying attention, legal cannabis is a big-dollar business model. Having generated $12.2 billion in global (legal) sales in 2018, according to figures from Arcview Market Research and BDS Analytics, the worldwide weed industry could make a run at $50 billion, or perhaps $75 billion, in annual sales by the time 2029-2030 rolls around, based on various Wall Street estimates.


Quebec cannabis sales totalled $71 million in first year

Quebec's provincially operated cannabis shops made $71 million in sales in their first year and sold the most cannabis in the country in terms of dollars and volume, but they still posted a $4.9-million loss to be covered by the provincial government.

The provincial cannabis corporation -- known as the SQDC -- said in a statement that the provincial government revenues from consumption and excise taxes totalled about $21.7 million between June 12, 2018 and March 30.

The first stores in the Quebec network opened on Oct. 17, the day recreational marijuana became legal in the country.

However, the stores had to reduce opening hours, plagued by supply challenges faced by all provinces no matter what business model they were employing.


THC’s Canndeo gets green light to manufacture medicinal cannabis extracts

THC Global’s (ASX: THC) wholly-owned subsidiary Canndeo has achieved a major milestone by securing a manufacturing licence to produce cannabis extracts and tinctures in Australia.

The Australian Office of Drug Control granted the licence to Canndeo, which now completes THC’s vertical integration strategy to cultivate its own cannabis strains, harvest and process the material to produce its own cannabis-based products for Australian and international markets.

“We are very pleased to be granted a manufacture licence, which now completes our ‘farm to pharma’ model,” THC chairman Steven Xu said.


Promise of marijuana leads scientists on search for evidence

Marijuana has been shown to help ease pain and a few other health problems, yet two-thirds of U.S. states have decided pot should be legal to treat many other conditions with little scientific backing.

At least 1.4 million Americans are using marijuana for their health, according to an Associated Press analysis of states that track medical marijuana patients.

The number of medical marijuana cardholders more than tripled in the last five years as more states jumped on the bandwagon. The analysis is based on data from 26 states and the District of Columbia. The total climbs to 2.6 million patients if California, Washington and Maine are included, the AP estimates.


Green Growth plans 70 new CBD shops in Brookfield Properties' U.S. malls

Green Growth Brands Inc. has signed a deal to open more than 70 new CBD stores at Brookfield Properties' shopping centres throughout the United States.

The Ohio-based cannabis company says these stores will sell CBD-infused personal care products under its existing Seventh Sense banner and under a new brand called Green Lily.

The chief executive of Brookfield Properties' retail group, Sandeep Mathrani, says it is the company's job to bring in retail offerings that consumers desire, and this includes Green Growth's CBD products.

Green Growth currently has seven shops within Brookfield Properties' portfolio.

Cannabidiol or CBD is a non-intoxicating compound which can be derived from cannabis or hemp and has been touted for its health benefits.


Subscribe to RSS - Medical Cannabis News